Avidian Wealth Enterprises LLC grew its stake in shares of The Allstate Co. (NYSE:ALL – Free Report) by 4.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,473 shares of the insurance provider’s stock after acquiring an additional 247 shares during the period. Avidian Wealth Enterprises LLC’s holdings in Allstate were worth $1,038,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of ALL. Allspring Global Investments Holdings LLC raised its position in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after purchasing an additional 472,040 shares in the last quarter. Raymond James & Associates increased its stake in shares of Allstate by 10.6% during the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after buying an additional 145,986 shares during the period. Dimensional Fund Advisors LP lifted its stake in Allstate by 3.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock worth $229,545,000 after acquiring an additional 47,038 shares during the period. Pathway Financial Advisers LLC grew its holdings in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in Allstate by 3.3% during the 2nd quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock valued at $160,948,000 after purchasing an additional 31,789 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Trading Up 2.0 %
NYSE ALL opened at $188.69 on Thursday. The Allstate Co. has a 12-month low of $127.93 and a 12-month high of $198.79. The company has a fifty day simple moving average of $188.89 and a two-hundred day simple moving average of $175.59. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock has a market cap of $49.97 billion, a P/E ratio of 12.22, a P/E/G ratio of 1.73 and a beta of 0.48.
Insider Activity at Allstate
In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 192,530 shares of company stock worth $34,967,665 over the last quarter. Insiders own 1.80% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the stock. The Goldman Sachs Group upped their price target on shares of Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. Wells Fargo & Company upped their target price on Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a report on Tuesday. UBS Group lifted their price target on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday. TD Cowen upped their price objective on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd. Finally, Roth Mkm reiterated a “buy” rating and issued a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Allstate has a consensus rating of “Moderate Buy” and a consensus target price of $209.50.
Get Our Latest Research Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
- Five stocks we like better than Allstate
- Which Wall Street Analysts are the Most Accurate?
- What a Trump Win Looks Like for the Market Now and Into 2025
- ESG Stocks, What Investors Should Know
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Roth IRA Calculator: Calculate Your Potential Returns
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.